Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
NEW YORK (Reuters Health) - Screening women for breast cancer costs the U.S. Medicare program $1 billion every year - about as much as it spends on treatment, according to a new study.
HONG KONG (Reuters) - The discovery that a protein that triggers milk production in women may also be responsible for making breast cancers aggressive could open up new opportunities for treatment of the most common and deadliest form of cancer among women.
A report issued by the U.S. Centers for Disease Control and Prevention shows that African-American women are diagnosed with breast cancer less often than white women but continue to experience higher death rates.
An analysis of data collected in the Surveillance, Epidemiology and End Results (SEER)-Medicare database between 2002 and 2007 shows that though newer, less invasive breast cancer staging procedures have become standard, African-American women were 12 percent less likely to have the less invasive surgery than their white peers.
Tamoxifen treatment for estrogen receptor-positive breast cancer is even more beneficial when taken for 10 years instead of five.
The American Society of Clinical Oncology recently published the results of its most current guidelines for follow-up care of women who completed treatment for primary breast cancer. The 2012 findings, published online in the Journal of Clinical Oncology in November, determined that no change to the existing guidelines is necessary.
Women with moderate cancer-related fatigue may benefit from acupuncture treatment, a recent clinical trial found. The study supports past research that shows acupuncture may help manage fatigue caused by cancer and other factors.
Results of an early analysis of a phase II clinical trial presented at the 2012 San Antonio Breast Cancer Symposium show that combining the aromatase inhibitor letrozole with the study medicine PD-0332991 increased median progression-free survival by 18.6 months compared to taking letrozole alone.
NEW YORK (Reuters Health) - A new review of existing evidence suggests that using magnetic resonance imaging to "stage" a woman's breast cancer before surgery might do more harm than good.
The U.S. Supreme Court on Friday agreed to decide whether human genes can be patented, a hotly contested issue with broad consequences for the future of gene-based medicine.